Panel II: Substance Use Disorder in Women and Families
Speaker IV: Dr. Adrian Dunlop, MBBS, PhD, GDipEpiBiostat, FAChAM, Area Director and Senior Staff Specialist, Drug and Alcohol Clinical Services for the Hunter New England Local Health District; Chief Addiction Medical Specialist in the NSW Ministry of Health; Conjoint Professor in the School of Medicine and Public Health at the University of Newcastle.
Presentation Title: Implementing a Parenting Intervention for Mothers and Fathers in Substance Use Treatment Programs
Bio: Dr. Adrian Dunlop, MBBS, PhD, GDipEpiBiostat, FAChAM, is Area Director and Senior Staff Specialist, Drug and Alcohol Clinical Services for the Hunter New England Local Health District, Chief Addiction Medicine Specialist in the NSW Ministry of Health, and Conjoint Professor in the Schools of Medicine and Public Health at the University of Newcastle. He is a Foundation Fellow of the Australasian Chapter of Addiction Medicine (FAChAM) in the Royal Australasian College of Physicians, Past-President of the Australasian Professional Society on Alcohol and other Drugs (APSAD), member of the College of Problems on Drug Dependence (USA), Society for the Study of Addiction (UK), and the International Society for Addiction Medicine. In 2005, he was awarded a Churchill Fellowship to investigate the treatment of opiate dependence in pregnancy. In 2010 he was awarded Clinical Leader of the Year by Hunter New England Health. In 2014 he was awarded the APSAD clinician award for excellence in Science, research and practice in the drug and alcohol field and was a 2015 James Rankin orator for APSAD. He has over two decades of experience in the drug and alcohol field, over 140 publications including 73 peer reviewed journal articles, 8 book chapters and a co-author on Australian guidelines on addiction management, and attracted on 30 grants including over $A14 million in collaborative competitive research funding.
Speaker V: Dr. Colleen Dell, PhD, Centennial Enhancement Chair in One Health and Wellness; Professor of Sociology and Public Health at the University of Saskatchewan; Senior Research Associate with the Canadian Centre on Substance Abuse.
Presentation Title: Identity, Culture and Healing from Opioid Use Disorder and other Addictions: Indigenous Women in Canada
Bio: Dr. Colleen Dell, PhD, is a Centennial Enhancement Chair in One Health and Wellness; Professor of Sociology and Public Health at the University of Saskatchewan; and Senior Research Associate with the Canadian Centre on Substance Abuse. Dr. Dell’s research interests include identity and stigma and their relationship to healing from drug addiction, substance abuse treatment and programming, self-harm among women and girls, the connection between youth resiliency and volatile substance misuse, animal assisted interventions as a healing approach to addictions and mental health, harm reduction, campus prevention initiatives, and research methodology and evaluation. Dr. Dell’s research areas are specific to Aboriginal populations, criminalized women, and drug using populations. Her research studies are grounded in a community-based participatory approach. Prior to her arrival at the University of Saskatchewan, Dr. Dell worked extensively at the community and national levels, including with the Elizabeth Fry Society of Manitoba, Correctional Service Canada, and the Senate of Canada.
Speaker VI: Dr. Kimberly Page, PhD, Professor and Chief of Epidemiology, Biostatistics, and Preventive Medicine in the Department of Internal Medicine at the University of New Mexico’s Health Sciences Center
Presentation Title: Who is a SMARTgirl? Demographics, Risk and HIV among Cambodian Female Entertainment and Sex Workers Participating in an HIV Risk Reduction Intervention in Cambodia
Bio: Dr. Kimberly Page, PhD, is a Professor and Chief of Epidemiology, Biostatistics, and Preventive Medicine in the Department of Internal Medicine at the University of New Mexico’s Health Sciences Center. Dr. Page leads nationally and internationally recognized research on HIV and viral hepatitis prevention in underserved and vulnerable populations, including people who inject drugs (PWID), and women engaged in transactional sex. She likes to say that her ‘laboratory’ is in the community, and embraces the challenges of working with hard-to-reach populations with her work in the U.S. and internationally. In addition to leading the country’s first trial testing a prophylactic HCV vaccine in PWID, she has launched new studies integrating HCV treatment and prevention in rural and urban New Mexico. She also collaborates with leading researchers and public health groups in the U.S and other countries to better understand and deliver global health knowledge and HIV and HCV prevention. She leads a multidisciplinary team of researchers in Cambodia where they recently implemented a large multi-level HIV prevention intervention aimed at reducing HIV risk due to in female sex and entertainment workers in 10 provinces. This project was an ‘implementation science’ project that included targeted interventions to reduce sexual risk, amphetamine type stimulant use, and economic opportunities.